A biotech company that develops sensors to detect explosives and other chemicals on planes and in airports is teaming up with Airbus to create a sensor that could detect passengers who are positive for COVID-19.
California-based Koniku and Airbus, which have been working since 2017 on contactless equipment that sniffs out chemicals, are trying to adapt that technology to sniff out pathogens, says Osh Agabi, founder and CEO of Koniku, in a blog post.
